Distribution and expression of soluble epoxide hydrolase in human brain

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 6, 2008, Pages 551-559

  Sura, Priyanka ^a   Sura, Radhakrishna ^a   Enayetallah, Ahmed E ^a   Grant, David F ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Central nervous system; Cerebral blood flow; Cytochrome P450 epoxygenase; Epoxyeicosatrienoic acids; Soluble epoxide hydrolase

Indexed keywords

EPOXIDE HYDROLASE;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN; CHOROID PLEXUS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROCHEMISTRY; OLIGODENDROGLIA; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; BRAIN; EPOXIDE HYDROLASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SOLUBILITY;

ANIMALIA;

EID: 43949116261     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.950659     Document Type: Article

References (38)

1. Al-Anizy M, Horley NJ, Kuo CW, Gillett LC, Laughton CA, Kendall D, Barrett DA, et al. (2006) Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J 273:936-947
2. Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR (1997) Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 28:1066-1072
3. Alkayed NJ, Narayanan J, Gebremedhin D, Medhora M, Roman RJ, Harder DR (1996) Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 27:971-979
4. Amruthesh SC, Falck JR, Ellis EF (1992) Brain synthesis and cerebrovascular action of epoxygenase metabolites of arachidonic acid. J Neurochem 58:503-510
5. Bjorkhem I, Meaney S (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24:806-815
6. Borhan B, Mebrahtu T, Nazarian S, Kurth MJ, Hammock BD (1995) Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem 231:188-200
7. Capdevila JH, Falck JR (2001) The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 285:571-576
8. Cashman JR, Hanks D, Weiner RI (1987) Epoxy derivatives of arachidonic acid are potent stimulators of prolactin secretion. Neuroendocrinology 46:246-251
9. Cronin A, Mowbray S, Durk H, Homburg S, Fleming I, Fisslthaler B, Oesch F, et al. (2003) The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc Natl Acad Sci USA 100:1552-1557
10. Dietschy JM, Turley SD (2004) Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375-1397
11. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC (1990) Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 259:H1171-H1177
12. EnayetAllah AE, French RA, Thibodeau MS, Grant DF (2004) Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52:447-454
13. EnayetAllah AE, Grant DF (2006) Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. Biochem Biophys Res Commun 341:254-260
14. Ghersi-Egea JF, Leininger-Muller B, Minn A, Siest G (1992) Drug metabolizing enzymes in the rat pituitary gland. Prog Brain Res 91:373-378
15. Guillemin I, Becker M, Ociepka K, Friauf E, Nothwang HG (2005) A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue. Proteomics 5:35-45
16. Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, Roman RJ (1998) Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke 29:229-234
17. Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, et al. (2005) Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension 45:759-765
18. Koerner IP, Jacks R, DeBarber AE, Koop D, Mao P, Grant DF, Alkayed NJ (2007) Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J Neurosci 27:4642-4649
19. Larsen BT, Gutterman DD, Hatourn OA (2006) Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest 36:293-300
20. Newman JW, Morisseau C, Harris TR, Hammock BD (2003) The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci USA 100:1558-1563
21. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276-1279
22. Oesch F, Schladt L, Hartmann R, Timms C, Worner W (1986) Rat cytosolic epoxide hydrolase. Adv Exp Med Biol 197:195-201
23. Ota K, Hammock BD (1980) Cytosolic and microsomal epoxide hydrolases: differential properties in mammalian liver. Science 207:1479-1481
24. Pacifici GM, Temellini A, Giuliani L, Rane A, Thomas H, Oesch F (1988) Cytosolic epoxide hydrolase in humans: development and tissue distribution. Arch Toxicol 62:254-257
25. Peng X, Carhuapoma JR, Bhardwaj A, Alkayed NJ, Falck JR, Harder DR, Traystman RJ, et al. (2002) Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors. Am J Physiol Heart Circ Physiol 283:H2029-H2037
26. Peng X, Zhang C, Alkayed NJ, Harder DR, Koehler RC (2004) Dependency of cortical functional hyperemia to forepaw stimulation on epoxygenase and nitric oxide synthase activities in rats. J Cereb Blood Flow Metab 24:509-517
27. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, et al. (2003) Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64:482-490
28. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131-185
29. Sandberg M, Hassett C, Adman ET, Meijer J, Omiecinski CJ (2000) Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275:28873-28881
30. Sato K, Emi M, Ezura Y, Fujita Y, Takada D, Ishigami T, Umemura S, et al. (2004) Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet 49:29-34
31. Shin JH, Engidawork E, Delabar JM, Lubec G (2005) Identification and characterisation of soluble epoxide hydrolase in mouse brain by a robust protein biochemical method. Amino Acids 28:63-69
32. Snyder GD, Yadagiri P, Falck JR (1989) Effect of epoxyeicosatrienoic acids on growth hormone release from somatotrophs. Am J Physiol 256:E221-E226
33. Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43:55-90
34. Spector AA, Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292:C996-C1012
35. Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK (2002) Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res 90:1020-1027
36. Tran KL, Aronov PA, Tanaka H, Newman JW, Hammock BD, Morisseau C (2005) Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase. Biochemistry 44:12179-12187
37. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276:36059-36062
38. Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, Luria A, et al. (2007) Soluble epoxide hydrolase: a novel therapeutic target in stroke. J Cereb Blood Flow Metab 27:1931-1940